Cancer cell biologist with 7+ years of doctoral and pre-doctoral research experience in oncogenic signaling, CRISPR functional genomics, and computational drug discovery. Demonstrated expertise in both wet-lab experimental biology and in silico approaches, with 5+ first-author peer-reviewed publications (2021–2025) and international recognition including an invited speaker role at a 2025 international conference. Specialized in ovarian cancer biology, drug repurposing, and the intersection of mechanistic pathway analysis with therapeutic development.